| GA22603-5mg |
|
114991-28-5 |
HIV-1 env Protein gp120 (278-292) (strains BH10, BH8, HXB2, HXB3, PV22)
|
0 |
C73H126N26O18 |
|
|
|
| GA22603-1mg |
|
114991-28-5 |
HIV-1 env Protein gp120 (278-292) (strains BH10, BH8, HXB2, HXB3, PV22)
|
0 |
C73H126N26O18 |
|
|
|
| GA22602-5mg |
|
130877-92-8 |
HIV Protease Substrate VI
|
0 |
C40H66N12O11 |
|
|
|
| GA22602-1mg |
|
130877-92-8 |
HIV Protease Substrate VI
|
0 |
C40H66N12O11 |
|
|
|
| GA22601-25mg |
|
128340-47-6 |
HIV Protease Substrate IV
|
0 |
C49H83N15O13 |
|
|
|
| GA22601-5mg |
|
128340-47-6 |
HIV Protease Substrate IV
|
0 |
C49H83N15O13 |
|
|
|
| GA22601-1mg |
|
128340-47-6 |
HIV Protease Substrate IV
|
0 |
C49H83N15O13 |
|
|
|
| GA22600-25mg |
|
179912-80-2 |
HIV Protease Substrate III-B (Native Sequence)
|
0 |
C51H90N18O14S |
|
|
|
| GA22600-5mg |
|
179912-80-2 |
HIV Protease Substrate III-B (Native Sequence)
|
0 |
C51H90N18O14S |
|
|
|
| GA22600-1mg |
|
179912-80-2 |
HIV Protease Substrate III-B (Native Sequence)
|
0 |
C51H90N18O14S |
|
|
|
| GA22599-25mg |
|
138608-20-5 |
HIV Protease Substrate III
|
0 |
C58H95N19O16 |
|
|
|
| GA22599-5mg |
|
138608-20-5 |
HIV Protease Substrate III
|
0 |
C58H95N19O16 |
|
|
|
| GA22599-1mg |
|
138608-20-5 |
HIV Protease Substrate III
|
0 |
C58H95N19O16 |
|
|
|
| GA22598-5mg |
|
147841-68-7 |
HIV (gp120) Fragment (318-327)
|
0 |
C48H80N16O12 |
|
|
|
| GA22598-1mg |
|
147841-68-7 |
HIV (gp120) Fragment (318-327)
|
0 |
C48H80N16O12 |
|
|
|
| GA22597-1mg |
|
115416-08-5 |
HIV (gp120) Fragment (308-331)
|
0 |
C114H199N41O31 |
|
|
|
| GA22597-005mg |
|
115416-08-5 |
HIV (gp120) Fragment (308-331)
|
0 |
C114H199N41O31 |
|
|
|
| GA22596-1mg |
|
113944-46-0 |
HIV (gp120) Fragment (254-274)
|
0 |
C95H162N28O30S |
|
|
|
| GA22596-005mg |
|
113944-46-0 |
HIV (gp120) Fragment (254-274)
|
0 |
C95H162N28O30S |
|
|
|
| GA22595-1mg |
|
— |
Histone H3 (1-21)-Gly-Gly-Lys(biotinyl) amide
|
0 |
C114H205N43O32S |
|
|
|
